• Quince Therapeutics, Inc. (NASDAQ:QNCX) Given Average Rating of "Buy" by Analysts

    Source: Buzz FX / 18 Mar 2025 03:31:16   America/Chicago


    Quince Therapeutics, Inc. (NASDAQ:QNCX) Given Average Rating of "Buy" by Analysts Written by MarketBeat March 18, 2025 Share Link copied to clipboard. Remove Ads Quince Therapeutics, Inc. ( NASDAQ:QNCX - Get Free Report ) has earned an aver
    Read more...
Share on,